Avidity Biosciences, Inc. - stock earnings
RNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -68.9 million USD | 3.5 million USD |
| 2023Q4 | -60.4 million USD | 2.2 million USD |
| 2023Q3 | -52.4 million USD | 2.8 million USD |
| 2023Q2 | -47.0 million USD | 2.3 million USD |
| 2023Q1 | -47.2 million USD | 2.2 million USD |
| 2022Q4 | -47.7 million USD | 2.8 million USD |
| 2022Q3 | -42.3 million USD | 2.5 million USD |
| 2022Q2 | -44.5 million USD | 2.2 million USD |
| 2022Q1 | -34.0 million USD | 1.8 million USD |
| 2021Q4 | -38.5 million USD | 1.9 million USD |
| 2021Q3 | -29.3 million USD | 2.2 million USD |
| 2021Q2 | -26.4 million USD | 2.6 million USD |
| 2021Q1 | -23.8 million USD | 2.7 million USD |
| 2020Q4 | -16.3 million USD | 2.1 million USD |
| 2020Q3 | -11.4 million USD | 1.7 million USD |
| 2020Q2 | -10.6 million USD | 1.5 million USD |
| 2020Q1 | -6.1 million USD | 1.4 million USD |
| 2019Q4 | -10.4 million USD | 1.4 million USD |
| 2019Q3 | -6.7 million USD | 650000 USD |
| 2019Q2 | -5.1 million USD | 224000 USD |
| 2019Q1 | -2.5 million USD | ? USD |
| 2014Q2 | ? USD | 164000 USD |
| 2014Q1 | 10.0 million USD | 20.7 million USD |
| 2013Q4 | ? USD | 3.6 million USD |
| 2013Q3 | ? USD | 3.7 million USD |
| 2013Q2 | ? USD | 2.7 million USD |
| 2013Q1 | ? USD | 3.1 million USD |
| 2012Q4 | ? USD | 3.3 million USD |
| 2012Q3 | ? USD | 3.0 million USD |
| 2012Q2 | ? USD | 1.4 million USD |
| 2012Q1 | ? USD | 2.6 million USD |
| 2011Q4 | ? USD | 11.3 million USD |
RNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -212.2 million USD | 9.6 million USD |
| 2022 | -169.1 million USD | 9.2 million USD |
| 2021 | -117.4 million USD | 9.3 million USD |
| 2020 | -44.0 million USD | 6.8 million USD |
| 2019 | -32.1 million USD | 2.3 million USD |
| 2018 | -11.9 million USD | 379000 USD |
| 2013 | ? USD | 13.1 million USD |
| 2012 | ? USD | 10.4 million USD |
| 2011 | ? USD | 11.3 million USD |
RNA
Price: $27.45
52 week price:
Earnings Per Share: -2.91 USD
P/E Ratio: -4.50
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 810900
Market Capitalization: 2.5 billion